genomics Latest News

Attend this panel discussion just added as part of CHI’s Bioinformatics in the Genome Era conference taking place February 13-15, 2013 at the Moscone North Convention Center in San Francisco, CA, part of the Molecular Med TRI-CON 2013.

Equinome, a leading Irish equine genomics company and a University College Dublin spin-out company, today announced that it is establishing a sales and marketing office in Australia.

Cleanascite™ from Biotech Support Group cleans up samples and it extends the life of membrane and chromatographic columns for large scale monoclonal antibody purification

UPCK™ Urine Protein Enrichment/Concentration Kit features a urinary protein enrichment optimized protocol for sample preparation and downstream analysis of urine samples

New CytoSure™ ISCA +SNP array for accurate detection of copy number changes and loss of heterozygosity using a single array

New CytoSure™ Haematological Cancer +SNP array delivers single chip detection of CNVs, SNPs and LOH in haematological malignancies

Dr. Leach will participate in a keynote session at this conference scheduled for Feb. 21-23, 2012, San Francisco, CA. The conference is organized by Cambridge Healthtech Institute.

This conference is part of the Molecular Med TRI-CON 2012 event on February 21-23, 2012 at the Moscone North Convention Center in San Francisco, CA. Advance registration discounts ends on January 13.

Insight Pharma Reports Announces Next-Generation Mass Spectrometry: Technology Advances and Applications, Authored by K. John Morrow, Jr., PhD.

Hear talks on NGS Data Management, and the impact of Sequencing on personalized medicine. This conference will take place on September 26-28, 2011 in Providence, RI. Early registration discounts will be offered until July 29.

Cypher Genomics: Ahead of the Curve A San Diego Company is Poised to Lead the Genome Interpretation Industry SAN DIEGO, C.A., Mar.

Attend this panel discussion just added as part of CHI’s Bioinformatics in the Genome Era conference taking place February 13-15, 2013 at the Moscone North Convention Center in San Francisco, CA, part of the Molecular Med TRI-CON 2013.

Equinome, a leading Irish equine genomics company and a University College Dublin spin-out company, today announced that it is establishing a sales and marketing office in Australia.

Now Available on www.Bio-ITWorld.com: Turning Genomics Data into Practical Insight

Researchers used AlbuVoid™ for serum albumin depletion for secretome sample preparation. Albumin was depleted from cell culture in serum containing medium using AlbuVoid™ to isolate and identify low abundance proteins.

ProCipitate™ is high throughput, high yield, and cost efficient for small or large sample genomic DNA enrichment. It is compatible with high throughput genomic DNA isolation and produces high quality DNA over alternative bind and elute systems.

Cleanascite™ from Biotech Support Group cleans up samples and it extends the life of membrane and chromatographic columns for large scale monoclonal antibody purification

UPCK™ Urine Protein Enrichment/Concentration Kit features a urinary protein enrichment optimized protocol for sample preparation and downstream analysis of urine samples

Hemoglobin Depletion Plus Protein Enrichment From Dried Blood Spot (Blood Card) Technology

Signup to attend protein enrichment webinar series to explore proteomics and genomic sample preparation products and research featuring albumin depletion, urine protein enrichment, glycoproteins enrichment.

Arrowhead Publishers & Conferences has just announced a new panel session to take place at their 4th Annual Personalized medicine Conference (Boston, MA, September 12-13, 2012) entitled: The Angel Investor & Venture Capital Perspective

September 12 & 13, hear speakers tackle the issues driving, as well as restraining, the clinical delivery of personalized medicine, including coding and reimbursement, whole genome sequencing, and market access challenges for companion diagnostics.

Cambridge Healthtech Institute (CHI) will host this 3 hour short course prior to the start of its Innovative Tissue-Based Diagnostics: Decoding Cancer & Other Maladies conference.

New CytoSure™ ISCA +SNP array for accurate detection of copy number changes and loss of heterozygosity using a single array

IDT’s DECODED newsletter discusses research carried out at the Hubrecht Institute

New CytoSure™ Haematological Cancer +SNP array delivers single chip detection of CNVs, SNPs and LOH in haematological malignancies

Latest issue of IDT’s Decoded newsletter explains the fundamentals of artificial gene construction

IDT’s Decoded Features a Conversation with Industry Expert Dr Jo Vandesompele

Dr. Leach will participate in a keynote session at this conference scheduled for Feb. 21-23, 2012, San Francisco, CA. The conference is organized by Cambridge Healthtech Institute.

This conference is part of the Molecular Med TRI-CON 2012 event on February 21-23, 2012 at the Moscone North Convention Center in San Francisco, CA. Advance registration discounts ends on January 13.

NGS Leaders community to host industry discussion on key challenge of next-generation sequencing data

Exciting new genomics technology can deliver better treatments for less money - It is estimated that only half of all prescribed medicines work on the individual patient

Navigating the Future of Genomic Technologies. March 5-8, 2012 at the Hilton San Diego Resort

BioDatomics is a software/hardware platform supported by cutting edge data storage & delivery technologies and can deliver all the computational power required for high throughput techniques in the discovery of disease treatment, origin & prevention.

Innovation in the design of vaccines is rapidly expanding their use, safety, and effectiveness for disease prevention and therapeutic interventionsis examined in a special issue of OMICS: A Journal of Integrative Biology .

Technology development in the life sciences sector received a much-needed boost with the announcement of five projects funded through Genome BC’s Proof of Concept (POC) Program. The program promises close to $9M to accelerate...

Insight Pharma Reports Announces Next-Generation Mass Spectrometry: Technology Advances and Applications, Authored by K. John Morrow, Jr., PhD.

Hear talks on NGS Data Management, and the impact of Sequencing on personalized medicine. This conference will take place on September 26-28, 2011 in Providence, RI. Early registration discounts will be offered until July 29.

Sigma® Life Science Launches Genetically Modified Human Cell Lines for Breast Cancer Research CompoZr® ZFN-modified breast cancer cell lines will accelerate drug discovery and enhance basic research

Canadian scientists are now part of an International team compiling an enormous bank of resources for research into the functions of all known genes.

“Rusts,” a group of fungi that attack and damage plants and trees, cost the international agriculture and forestry sectors billions of dollars in lost revenue every year, with an estimated loss of $200 million a year due to the destruction of...

Scientists have set a new standard for studying outbreaks of infectious disease by combining advanced genomics with a detailed map of the social relationships between cases to investigate a recent outbreak of tuberculosis in a BC community.

A Vancouver pediatric pathologist is leading the team that will explore the genomes (DNA) of four of the most challenging childhood cancers known.

Meiogenix and CIRAD signed a collaboration agreement to evaluate the impact of Meiogenix’s SpiX™ technology in modulating meiotic homologous recombination in rice leading to the identification of new varieties of rice with commercial potential.

New Biotechnology market report from Markets and Markets: "Top 10 Drug Delivery Technologies (2010 - 2015)"

Fast market research recommends "top 10 drug discovery technologies - strategic analysis and global forecasts" from markets and markets, now available

Meiogenix SAS, a French start-up biotech company developing of a new genomic technology, closed its first round of financing of 1,2M ! from Kurma Biofund, a French venture capital fund focused in Life Sciences.

The Alan and Priscilla Oppenheimer Foundation announced today that, in collaboration with the Personal Genome Project (PGP), it has begun the process of sequencing the first full human genome in the next major phase of that project, the PGP-1K.

Leading Professionals From Pharmaceutical and Biotechnology Companies Examine Advancements in Genomic Research

Deciphering the Sequencing Data Deluge Today

First-of-its kind project in translational cancer research aimed to produce pioneering discoveries and affordable clinical solutions in cancer care.

Genomic Expression, Inc. is featured at the Emerging Medical Technologies Spotlight Meeting today, where Gitte Pedersen, CEO delivered a 10-minute CEO presentation.

This report examines technology developments, trends, manufacturing, and supply of hESCs

Genomic Expression, Inc. has been selected to present at the OneMedForum investor conference in New York Wednesday, June 30, 2010 at 10:30 AM at the Roosevelt Hotel in New York.

The 5th BIO KOREA 2010 Conference & Exhibition will be held from September 1 to 3, 2010 at COEX in Seoul/Korea. BIO KOREA of this year offers a variety of high-level conference, international exhibition and partnership events.

International business consultancy group, Bridge4Bio employs its ten-strong global consultant network to help life sciences and biotechnology companies progress their business growth plans faster, more efficiently and at a lower cost

ECI Biotech of Worcester, MA, a premier developer of low cost and rapid diagnostics trademarked as ExpressDetect, has received a $511K Phase II Grant to develop a hand-held diagnostic tool for point-of-care detection of infection in chronic wounds.

Bridge4Bio, an international business consultancy group focused on promoting the growth of life sciences and biotech companies, is targeting 4 strategic areas to assist both startups and established companies plan and grow their businesses globally.

Biota Sciences serves researchers in vertebrate, invertebrate and other species, leveraging its proprietary next-gen sequencing technology to meet its clients' goals.

Hudson Robotics, Inc. today introduced the new VaryScreen™ ADME-Tox integrated workstation for faster, accurate and more efficient profiling of the absorption, distribution, metabolism and excretion (ADME) properties of drug molecules.